MDRP has teamed up with several of the speakers at this year's Medicaid Drug Rebate Program to share some of their insights on the current healthcare reform and how it will effect the industry leading up to the conference.
Katie Lapins, Principal, Government Pricing Specialists shared her insights on these questions with us:
- We often hear the terms, “Medicaid” and “Government Programs” used interchangeably. What is meant by each of these terms, how are they similar and how are they different?
- Tell us about your current work and focus on the MDRP and Government Programs.
- You are leading a panel session at September MDRP on Translating the GP Impact of Healthcare Reform for Senior Management; tell us a little about the session and why it is important.
- With all of the changes introduced by healthcare reform, what recommendations do you have for a manufacturer if they were already unsure about their compliance status and are unsure where to begin?
To download the podcast, visit the MDRP webpage.
For a transcript of the podcast, click here.
About Us
Health Care Insights - From Policy to Practice is the trusted source for news and commentary from the nation's leading Health Care Events such as Medicaid Drug Rebate Program Summit (MDRP), Medicaid Managed Care Congress (MMCC), FDA/CMS to inform Health Plans and Pharmaceutical Manufacturers on the latest developments on Medicare, Medicaid Managed Care, Government Programs, and Health Insurance Exchanges.
Topics we cover include reform, best business practices, the latest innovations, and novel payment models.
Subscribe
Blog Archive
-
▼
2010
(111)
-
▼
June
(8)
- CMS starts campaing to warn seniors of Medicare fraud
- MDRP Podcast: Katie Lapins, Principal, Government ...
- Crack Down on the C-Suite: What impact will this h...
- California hospital enrolls in the 340B Program
- INDUSTRY ALERT: OFFICIAL CALL FOR PAPERS: 8TH ANNU...
- States working to cut Medicaid Deficit
- 8th Annual Medicare Congress Conference
- New Jersey receives settlement from Aventis
-
▼
June
(8)
No comments:
Post a Comment